Type II respiratory immunophlogosis: review of our case series in the light of the Clinical-Cytological-Grading (CGC)
Authors/Creators
Description
Abstract: In a recent scientific publication Gelardi and al. described the Clinical-Cytological-Grading as an additional score to be used in association with SNOT-22 et al NPS in the evaluation of patients with chronic sinusitis and nasal polyposis in order to identify those who are correctly eligible for biological therapy in clinical practice. In this paper, the authors review their series of patients with nasal polyposis treated with monoclonal antibodies in order to assess whether the prescription of the therapy was appropriate in the light of the GCC.
Keywords: Chronic Rhinosinositis, nasal polyps, monoclonal antibodies, mepolizumab, dupilumab, Clinical-Cytological-Grading.
Title: Type II respiratory immunophlogosis: review of our case series in the light of the Clinical-Cytological-Grading (CGC)
Author: F.Asprea, G.Lucchesi, D. Costanzo, G.Micali
International Journal of Healthcare Sciences
ISSN 2348-5728 (Online)
Vol. 10, Issue 2, October 2022 - March 2023
Page No: 187-190
Research Publish Journals
Website: www.researchpublish.com
Published Date: 17-January-2023
DOI: https://doi.org/10.5281/zenodo.7544112
Paper Download Link (Source)
Notes
Files
Type II respiratory immunophlogosis-17012023-3.pdf
Files
(241.9 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:d75353ddc402171a947c81fd0ab20ac8
|
241.9 kB | Preview Download |
Additional details
Related works
- Is derived from
- Journal article: https://www.researchpublish.com/papers/type-ii-respiratory-immunophlogosis-review-of-our-case-series-in-the-light-of-the-clinical-cytological-grading-cgc (URL)
- Is published in
- Journal article: 2348-5728 (ISSN)